Compugen Presents Predictive Drug Target Discovery Platform at European Antibody Conference.
Business Wire › November 30, 2011
Linked as:
Extract
Compugen Presents Predictive Drug Target Discovery Platform at European Antibody Conference.
Presentation by Dr. Anat Cohen-Dayag, Compugen's CEO, includes results for two promising novel targets for antibody-based therapy
GENEVA -- Speaking today at the plenary session of the 7th Annual European Antibody Congress in Geneva, Dr. Anat Cohen-Dayag, President and CEO of Compugen Ltd. (NASDAQ: CGEN), presented Compugen's Antibody Target Discovery Platform, one of the Company's predictive discovery platforms for novel therapeutic targets. As...See the full content of this document
Sponsored links
